SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Xencor (XNCR) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (18)6/9/2014 9:03:43 AM
From: gcrispin  Respond to of 136
 
Again, thanks for starting this board and posting information. What impresses me is the patent portfolio that XNCR is developing and I wonder, theoretically, how many improvements are possible for the Fc domain. Their strategy reminds me of Mederex and we know how that story ended.

faqs.org



To: scaram(o)uche who wrote (18)6/28/2014 4:35:58 PM
From: tuck  Read Replies (1) | Respond to of 136
 
Thoughts on how differentiated the non-asthma programs (RA & ALL programs) are from competing programs? Most of the data coming up in the next several has to do with the non-asthma programs.

TIA & Cheers, Tuck


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News